The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Vagus Nerve Stimulation Market Report By Product (Implantable VNS Device, External VNS Device), By Application (Epilepsy, Depression, Migraine), By Biomaterial (Metallic, Ceramics, Polymeric), By End-use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11220149
January 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Vagus Nerve Stimulation Market is presumed to reach the market size of nearly USD 1032.96 MN by 2028 from USD 478.81 MN in 2021 with a CAGR of 11.61% under the study period 2022 - 2028.
Vagus nerve stimulation (VNS) is a scientific remedy that involves the use of electrical impulses to stimulate the vagus nerve, a cranial nerve that runs from the brainstem to the abdomen. The vagus nerve is involved in several important functions in the body, including heart rate, digestion, and the control of inflammation. VNS is typically used to treat conditions that include seizures, such as epilepsy and depression. The procedure for VNS involves the surgical implantation of a small device, called a vagus nerve stimulator, under the skin in the chest.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of vagus nerve stimulation. The growth and trends of vagus nerve stimulation industry provide a holistic approach to this study.
By Product
By Application
By Biomaterial
By End-Use
This section covers the regional outlook, which accentuates current and future demand for the Vagus Nerve Stimulation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the vagus nerve stimulation market include LivaNova LLC, electroCore, MicroTransponder Inc., Parasym, Cerebral Rx. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Vagus nerve stimulation (VNS) is a scientific remedy that involves the use of electrical impulses to stimulate the vagus nerve, a cranial nerve that runs from the brainstem to the abdomen. The vagus nerve is involved in several important functions in the body, including heart rate, digestion, and the control of inflammation. VNS is typically used to treat conditions that include seizures, such as epilepsy and depression. The procedure for VNS involves the surgical implantation of a small device, called a vagus nerve stimulator, under the skin in the chest.
Market Dynamics
The market growth is expected to have risen because it is considered a safe and effective treatment for certain medical conditions. As VNS has been authorized by the US Food and Drug Administration (FDA) for the remedy of epilepsy and depression, and it is effective in clinical trials. Moreover, it is a non-pharmacological treatment, meaning it does not involve the use of drugs, which may be attractive to some people. Furthermore, many healthcare providers are now trained in using VNS and can offer it to their patients, which boosts the market growth.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of vagus nerve stimulation. The growth and trends of vagus nerve stimulation industry provide a holistic approach to this study.
Market Segmentation
This section of the vagus nerve stimulation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Product
- Implantable VNS Device
- External VNS Device
By Application
- Epilepsy
- Depression
- Migraine
By Biomaterial
- Metallic
- Ceramics
- Polymeric
By End-Use
- Hospitals
- Neurology Clinics
- Ambulatory Surgical Centers
- Research Centers
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Vagus Nerve Stimulation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Vagus Nerve Stimulation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the vagus nerve stimulation market include LivaNova LLC, electroCore, MicroTransponder Inc., Parasym, Cerebral Rx. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
Frequently Asked Questions (FAQs) about this Report
b. For the year 2021, the global market size for vagus nerve stimulation was valued at USD 478.81 Million.
b. The global vagus nerve stimulation market growth is estimated to be close to 11.61% between 2023 and 2028.
b. In the global vagus nerve stimulation market, North America holds the largest market share.
b. The global vagus nerve stimulation market is segmented by Product (Implantable VNS Device, External VNS Device), by Application (Epilepsy, Depression, Migraine), by Biomaterial (Metallic, Ceramics, Polymeric), by End-use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers).
b. The leading players in the global vagus nerve stimulation market are LivaNova LLC, electroCore, MicroTransponder Inc., Parasym, Cerebral Rx.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . VAGUS NERVE STIMULATION – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Product
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Biomaterial
3.7.4 Market Attractiveness Analysis By End-use
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL VAGUS NERVE STIMULATION MARKET ANALYSIS BY PRODUCT
6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Implantable VNS Device Historic and Forecast Sales by Regions
6.5 External VNS Device Historic and Forecast Sales by Regions
7 . GLOBAL VAGUS NERVE STIMULATION MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Epilepsy Historic and Forecast Sales by Regions
7.5 Depression Historic and Forecast Sales by Regions
7.6 Migraine Historic and Forecast Sales by Regions
8 . GLOBAL VAGUS NERVE STIMULATION MARKET ANALYSIS BY BIOMATERIAL
8.1 Overview by Biomaterial
8.2 Historical and Forecast Data
8.3 Analysis by Biomaterial
8.4 Metallic Historic and Forecast Sales by Regions
8.5 Ceramics Historic and Forecast Sales by Regions
8.6 Polymeric Historic and Forecast Sales by Regions
9 . GLOBAL VAGUS NERVE STIMULATION MARKET ANALYSIS BY END-USE
9.1 Overview by End-use
9.2 Historical and Forecast Data
9.3 Analysis by End-use
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Neurology Clinics Historic and Forecast Sales by Regions
9.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
9.7 Research Centers Historic and Forecast Sales by Regions
10 . GLOBAL VAGUS NERVE STIMULATION MARKET ANALYSIS BY GEOGRAPHY
10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
10.3.1. Overview, Historic and Forecast Sales Analysis
10.3.2. North America By Segment Sales Analysis
10.3.3. North America By Country Sales Analysis
10.3.4. United State Sales Analysis
10.3.5. Canada Sales Analysis
10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
10.4.1. Overview, Historic and Forecast Sales Analysis
10.4.2. Europe by Segment Sales Analysis
10.4.3. Europe by Country Sales Analysis
10.4.4. United Kingdom Sales Analysis
10.4.5. France Sales Analysis
10.4.6. Germany Sales Analysis
10.4.7. Italy Sales Analysis
10.4.8. Russia Sales Analysis
10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
10.5.1. Overview, Historic and Forecast Sales Analysis
10.5.2. Asia Pacific by Segment Sales Analysis
10.5.3. Asia Pacific by Country Sales Analysis
10.5.4. China Sales Analysis
10.5.5. India Sales Analysis
10.5.6. Japan Sales Analysis
10.5.7. South Korea Sales Analysis
10.5.8. Australia Sales Analysis
10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
10.6.1. Overview, Historic and Forecast Sales Analysis
10.6.2. Latin America by Segment Sales Analysis
10.6.3. Latin America by Country Sales Analysis
10.6.4. Brazil Sales Analysis
10.6.5. Argentina Sales Analysis
10.6.6. Peru Sales Analysis
10.6.7. Chile Sales Analysis
10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
10.7.1. Overview, Historic and Forecast Sales Analysis
10.7.2. Middle East & Africa by Segment Sales Analysis
10.7.3. Middle East & Africa by Country Sales Analysis
10.7.4. Saudi Arabia Sales Analysis
10.7.5. UAE Sales Analysis
10.7.6. Israel Sales Analysis
10.7.7. South Africa Sales Analysis
10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE VAGUS NERVE STIMULATION COMPANIES
11.1. Vagus Nerve Stimulation Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments
12 . COMPANY PROFILES OF VAGUS NERVE STIMULATION INDUSTRY
12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. LivaNova LLC
12.3.1. Company Overview
12.3.2. Company Revenue
12.3.3. Products
12.3.4. Recent Developments
12.4. electroCore
12.4.1. Company Overview
12.4.2. Company Revenue
12.4.3. Products
12.4.4. Recent Developments
12.5. MicroTransponder Inc.
12.5.1. Company Overview
12.5.2. Company Revenue
12.5.3. Products
12.5.4. Recent Developments
12.6. Parasym
12.6.1. Company Overview
12.6.2. Company Revenue
12.6.3. Products
12.6.4. Recent Developments
12.7. Cerebral Rx
12.7.1. Company Overview
12.7.2. Company Revenue
12.7.3. Products
12.7.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Product (USD MN)
- Implantable VNS Device Market Sales by Geography (USD MN)
- External VNS Device Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Epilepsy Market Sales by Geography (USD MN)
- Depression Market Sales by Geography (USD MN)
- Migraine Market Sales by Geography (USD MN)
- Analysis by Biomaterial (USD MN)
- Metallic Market Sales by Geography (USD MN)
- Ceramics Market Sales by Geography (USD MN)
- Polymeric Market Sales by Geography (USD MN)
- Analysis by End-use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Neurology Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgical Centers Market Sales by Geography (USD MN)
- Research Centers Market Sales by Geography (USD MN)
- Global Vagus Nerve Stimulation Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Vagus Nerve Stimulation Report
- Market Research Process
- Market Research Methodology
- Global Vagus Nerve Stimulation Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Biomaterial
- Market Attractiveness Analysis by End-use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product (USD MN)
- Implantable VNS Device Market Sales by Geography (USD MN)
- External VNS Device Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Epilepsy Market Sales by Geography (USD MN)
- Depression Market Sales by Geography (USD MN)
- Migraine Market Sales by Geography (USD MN)
- Global Market Analysis by Biomaterial (USD MN)
- Metallic Market Sales by Geography (USD MN)
- Ceramics Market Sales by Geography (USD MN)
- Polymeric Market Sales by Geography (USD MN)
- Global Market Analysis by End-use (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Neurology Clinics Market Sales by Geography (USD MN)
- Ambulatory Surgical Centers Market Sales by Geography (USD MN)
- Research Centers Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments